Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 1Meningeal Neoplasms 1Melanoma 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × gadopiclenol × 1 year × Clear all
NCT06086704 2026-05-18

Study of 18F-FFNP Breast PET/MRI

University of Wisconsin, Madison

Phase 2 Recruiting
53 enrolled
Breast

Breast Neoplasms

NCT07415018 2026-04-14

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
40 enrolled

Meningeal Neoplasms

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting
180 enrolled
DermatologicThoracic

Lung Neoplasms, Melanoma

NCT06226129 2025-10-20

Gadopiclenol in Contrast Enhanced MRI of the Prostate

Columbia University

Phase 4 Recruiting
150 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡